# Metformin IN Asthma for Overweight and Obese Individuals (MINA)

> **NCT06273072** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 100 (estimated)

## Conditions studied

- Asthma
- Asthma Chronic
- Overweight and Obesity

## Interventions

- **DRUG:** Metformin hydrochloride extended-release tablets
- **DRUG:** Visually identical placebo Metformin hydrochloride extended-release tablets

## Key facts

- **NCT ID:** NCT06273072
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-09
- **Primary completion:** 2026-09-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273072, "Metformin IN Asthma for Overweight and Obese Individuals (MINA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06273072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*